{
"NDC": {
"NDCCode": "0054-0821-58",
"PackageDescription": "1 BOTTLE in 1 CARTON (0054-0821-58) / 240 mL in 1 BOTTLE",
"NDC11Code": "00054-0821-58",
"ProductNDC": "0054-0821",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Tofacitinib Solution",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Tofacitinib",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20260603",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA216878",
"LabelerName": "Hikma Pharmaceuticals USA Inc.",
"SubstanceName": "TOFACITINIB CITRATE",
"StrengthNumber": "1",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-06-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260603",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}